371 related articles for article (PubMed ID: 33345731)
1. On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases.
Legname G; Scialò C
Prion; 2020 Dec; 14(1):257-270. PubMed ID: 33345731
[TBL] [Abstract][Full Text] [Related]
2. The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates.
Scialò C; Legname G
Prog Mol Biol Transl Sci; 2020; 175():297-323. PubMed ID: 32958237
[TBL] [Abstract][Full Text] [Related]
3. Role of cellular prion protein in interneuronal amyloid transmission.
Del Río JA; Ferrer I; Gavín R
Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
[TBL] [Abstract][Full Text] [Related]
4. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
[TBL] [Abstract][Full Text] [Related]
5. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.
Goedert M; Masuda-Suzukake M; Falcon B
Brain; 2017 Feb; 140(2):266-278. PubMed ID: 27658420
[TBL] [Abstract][Full Text] [Related]
6. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
8. Different tau fibril types reduce prion level in chronically and de novo infected cells.
Celauro L; Burato A; Zattoni M; De Cecco E; Fantuz M; Cazzaniga FA; Bistaffa E; Moda F; Legname G
J Biol Chem; 2023 Aug; 299(8):105054. PubMed ID: 37454740
[TBL] [Abstract][Full Text] [Related]
9. The Unexposed Secrets of Prion Protein Oligomers.
Wang G; Wang M; Li C
J Mol Neurosci; 2015 Aug; 56(4):932-937. PubMed ID: 25823438
[TBL] [Abstract][Full Text] [Related]
10. Sensing α-Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration.
Brás IC; Lopes LV; Outeiro TF
Mov Disord; 2018 Nov; 33(11):1675-1684. PubMed ID: 30423195
[TBL] [Abstract][Full Text] [Related]
11. Prion-Like Characteristics of Polyglutamine-Containing Proteins.
Pearce MMP; Kopito RR
Cold Spring Harb Perspect Med; 2018 Feb; 8(2):. PubMed ID: 28096245
[TBL] [Abstract][Full Text] [Related]
12. Potential mechanisms and implications for the formation of tau oligomeric strains.
Gerson JE; Mudher A; Kayed R
Crit Rev Biochem Mol Biol; 2016; 51(6):482-496. PubMed ID: 27650389
[TBL] [Abstract][Full Text] [Related]
13. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
14. PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins.
Corbett GT; Wang Z; Hong W; Colom-Cadena M; Rose J; Liao M; Asfaw A; Hall TC; Ding L; DeSousa A; Frosch MP; Collinge J; Harris DA; Perkinton MS; Spires-Jones TL; Young-Pearse TL; Billinton A; Walsh DM
Acta Neuropathol; 2020 Mar; 139(3):503-526. PubMed ID: 31853635
[TBL] [Abstract][Full Text] [Related]
15. Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein.
Nieznanska H; Boyko S; Dec R; Redowicz MJ; Dzwolak W; Nieznanski K
Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166209. PubMed ID: 34246750
[TBL] [Abstract][Full Text] [Related]
16. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
17. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
Sarnataro D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819
[TBL] [Abstract][Full Text] [Related]
18. The prion protein in human neurodegenerative disorders.
Kovacs GG; Zerbi P; Voigtländer T; Strohschneider M; Trabattoni G; Hainfellner JA; Budka H
Neurosci Lett; 2002 Sep; 329(3):269-72. PubMed ID: 12183028
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication.
Aulić S; Masperone L; Narkiewicz J; Isopi E; Bistaffa E; Ambrosetti E; Pastore B; De Cecco E; Scaini D; Zago P; Moda F; Tagliavini F; Legname G
Sci Rep; 2017 Aug; 7(1):10050. PubMed ID: 28855681
[TBL] [Abstract][Full Text] [Related]
20. The cellular prion protein (PrP
Urrea L; Ferrer I; Gavín R; Del Río JA
Prion; 2017 Jul; 11(4):226-233. PubMed ID: 28759332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
